Qiuling Shi
Impact in
- Oncology top 2%
- Cancer survivorship and care
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
Papers in
- Oncology 61
- Cancer survivorship and care 35
- Cancer Treatment and Pharmacology 15
-
- Lung Cancer Diagnosis and Treatment 17
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Charles S. Cleeland (74 shared papers)Xin Shelley Wang (66 shared papers)Tito R. Mendoza (33 shared papers)Loretta A. Williams (40 shared papers)Margaret R. Spitz (10 shared papers)Qingyi Wei (10 shared papers)Kevin Stein (2 shared papers)Tenbroeck Smith (2 shared papers)
- Journals
- International Journal of Hyperthermia (17 papers)Journal of Clinical Oncology (14 papers)Blood (12 papers)Annals of Surgical Oncology (10 papers)BMJ Open (9 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Qiuling Shi
221 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 131
- Oncology 1.3k
- Otorhinolaryngology 152
- Hematology 229
- Anesthesiology and Pain Medicine 104
- Rheumatology 250
Countries citing papers authored by Qiuling Shi
This map shows the geographic impact of Qiuling Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiuling Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiuling Shi more than expected).
Fields of papers citing papers by Qiuling Shi
This network shows the impact of papers produced by Qiuling Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiuling Shi. The network helps show where Qiuling Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Qiuling Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 249 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 267 | |
| 2 | 2011 | 219 | |
| 3 | 2011 | 157 | |
| 4 | 2010 | 154 | |
| 5 | 2016 | 123 | |
| 6 | Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340. | 1999 | 123 |
| 7 | 2018 | 111 | |
| 8 | 2012 | 97 | |
| 9 | 2015 | 96 | |
| 10 | 2004 | 95 | |
| 11 | 2005 | 67 | |
| 12 | 2010 | 67 | |
| 13 | 2020 | 66 | |
| 14 | 2017 | 66 | |
| 15 | 2008 | 65 | |
| 16 | 2009 | 64 | |
| 17 | 2005 | 63 | |
| 18 | 2014 | 60 | |
| 19 | 2014 | 58 | |
| 20 | 2017 | 54 |
About Qiuling Shi
Qiuling Shi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Surgery and Obstetrics and Gynecology, having authored 249 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cancer survivorship and care (35 papers), Lung Cancer Diagnosis and Treatment (17 papers), Cancer Treatment and Pharmacology (15 papers), Multiple Myeloma Research and Treatments (14 papers), Endometriosis Research and Treatment (14 papers), Uterine Myomas and Treatments (12 papers), Folate and B Vitamins Research (7 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Oncology (1.3k citations), Otorhinolaryngology (152 citations), Hematology (229 citations), Anesthesiology and Pain Medicine (104 citations) and Rheumatology (250 citations). Qiuling Shi has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Charles S. Cleeland, Xin Shelley Wang, Tito R. Mendoza, Loretta A. Williams, Margaret R. Spitz, Qingyi Wei, Kevin Stein, Tenbroeck Smith, Chiewkwei Kaw and Jared D. Michonski. Their work appears in journals such as International Journal of Hyperthermia, Journal of Clinical Oncology, Blood, Annals of Surgical Oncology and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.